ロード中...
The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic obstructive pulmonary disease (COPD). Spiolto(®) or Stiolto(®) is a fixed-dose combination (FDC) containing two long-acting bronchodilators, the long-acting muscarinic receptor antagonist tiotropium (TIO) and the l...
保存先:
| 出版年: | Ther Adv Respir Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475840/ https://ncbi.nlm.nih.gov/pubmed/31002020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619843426 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|